Us Bancorp \De\ Arvinas, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Arvinas, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,675 shares of ARVN stock, worth $31,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,675

Previous 1,988 15.74%

Holding current value

$31,958

Previous $52,000 21.15%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$23.66 - $32.73 $7,405 - $10,244	-313 Reduced 15.74%	1,675 $41,000
Q2 2024 Aug 06, 2024	SELL	$24.46 - $40.4 $7,558 - $12,483	-309 Reduced 13.45%	1,988 $52,000
Q1 2024 May 07, 2024	SELL	$36.38 - $52.31 $836 - $1,203	-23 Reduced 0.99%	2,297 $94,000
Q4 2023 Feb 09, 2024	BUY	$14.19 - $42.33 $24,009 - $71,622	1,692 Added 269.43%	2,320 $95,000
Q3 2023 Nov 03, 2023	SELL	$19.64 - $28.21 $549 - $789	-28 Reduced 4.27%	628 $12,000
Q2 2023 Aug 09, 2023	BUY	$21.73 - $31.43 $4,128 - $5,971	190 Added 40.77%	656 $16,000
Q1 2023 May 09, 2023	BUY	$26.15 - $37.26 $4,262 - $6,073	163 Added 53.8%	466 $12,000
Q4 2022 Feb 13, 2023	SELL	$32.47 - $57.24 $1,623 - $2,862	-50 Reduced 14.16%	303 $10,000
Q3 2022 Oct 27, 2022	SELL	$41.87 - $57.99 $10,048 - $13,917	-240 Reduced 40.47%	353 $16,000
Q2 2022 Aug 01, 2022	SELL	$36.01 - $74.24 $18,725 - $38,604	-520 Reduced 46.72%	593 $25,000
Q1 2022 May 11, 2022	SELL	$60.27 - $81.57 $1.1 Million - $1.49 Million	-18,264 Reduced 94.26%	1,113 $75,000
Q4 2021 Feb 11, 2022	SELL	$65.85 - $96.21 $23,705 - $34,635	-360 Reduced 1.82%	19,377 $1.59 Million
Q3 2021 Nov 10, 2021	BUY	$73.2 - $107.87 $200,934 - $296,103	2,745 Added 16.15%	19,737 $1.62 Million
Q2 2021 Aug 05, 2021	BUY	$60.45 - $84.26 $995,732 - $1.39 Million	16,472 Added 3167.69%	16,992 $1.31 Million
Q1 2021 Apr 28, 2021	BUY	$58.19 - $91.37 $21,704 - $34,081	373 Added 253.74%	520 $35,000
Q4 2020 Feb 04, 2021	BUY	$20.19 - $84.93 $2,967 - $12,484	147 New	147 $12,000
Q3 2020 Nov 10, 2020	SELL	$22.99 - $36.34 $13,862 - $21,913	-603 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$29.88 - $56.74 $24,830 - $47,150	-831 Reduced 57.95%	603 $20,000
Q1 2020 May 13, 2020	SELL	$33.0 - $54.5 $1,518 - $2,507	-46 Reduced 3.11%	1,434 $57,000
Q3 2019 Nov 08, 2019	BUY	$21.55 - $27.61 $31,894 - $40,862	1,480 New	1,480 $32,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account